Skip to main content
Log in

Osteoarthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measures

  • Published:
InflammoPharmacology Aims and scope Submit manuscript

Abstract

Aims

A study was designed to assess the effects of a standardized instructional videotape on reducing interobserver variability for several commonly used observer dependent outcome measures.

Methods

During a single day, six rheumatologists independently examined six patients with osteoarthritis (OA) in a predetermined order using a Latin square design, before and after viewing a standardized videotape demonstrating 13 examination techniques. Reliability coefficients were calculated based on variance components of the analysis of variance (ANOVA) table.

Results

Prestandardization reliability coefficients were >0.80 for all measures and remained above 0.80 following the intervention.

Conclusions

It is usually assumed that serial measurement in clinical trials should be performed by the same assessor because of concern regarding interobserver variability. However, the high levels of prestandardization interobserver reliability observed in this study indicate that, for these variables, serial measurements in a clinical trial could be made by different assessors, assuming they were equally skilled. This observation has important implications for outcome measurement in OA clinical trials. Although high levels of prestandardization reliability precluded the demonstration of any significant improvement, we speculate that the videotape might be effective in training less-experienced assessors. Reductions in observer variability have the potential to diminish sample size requirements for OA antirheumatic drug studies. The use of a videotape to achieve this goal offers cost and convenience advantages over one-on-one training procedures, and this method should be further assessed in less-experienced assessors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bellamy N, Anastassiades TP, Buchanan WW et al. Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1991;18:1893–1900.

    PubMed  CAS  Google Scholar 

  2. Bellamy N, Carette S, Ford PM et al. Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1992;19:436–43.

    PubMed  CAS  Google Scholar 

  3. Bellamy N, Buchanan WW, Esdaile JM et al. Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1991;18:1701–8.

    PubMed  CAS  Google Scholar 

  4. Bellamy N, Bell MJ, Carette S et al. Estimation of observer reliability and sample size calculation parameters for outcome measures in fibromyalgia clinical trials. Inflammopharmacology. 1994;2:345–60.

    Google Scholar 

  5. Bellamy N, Buchanan WW. Outcome measurement in osteoarthritis clinical trials: the case for standardization. Clin Rheumatol. 1984;3:293–303.

    Article  PubMed  CAS  Google Scholar 

  6. Atlas of Standard Radiographs—The Epidemiology of Chronic Rheumatism. Vol. 2. Philadelphia: F.A. Davis, 1963.

  7. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35:498–502.

    Article  PubMed  CAS  Google Scholar 

  8. US Department of Health and Human Services, Guidelines for the Clinical Evaluation of Anti-Inflammatory and Anti-Rheumatic Drugs (Adults and Children). Public Health Service, Food and Drug Administration, April 1988, p. 12–15.

  9. Guidelines for the Clinical Investigation of Drugs Used in Rheumatic Diseases, European Drug Guideline Series 5, World Health Organization, Regional Office for Europe, Copenhagen, European League Against Rheumatism, March 1985, p.21–24.

  10. ARA Glossary Committee, American Rheumatism Association: Dictionary of the Rheumatic Diseases, Vol. I: Signs and Symptoms. New York: Contact Press, 1982.

    Google Scholar 

  11. Box GEP, Hunter WG, Hunter JS. Statistics for Experimenters. New York: John Wiley, 1978.

    Google Scholar 

  12. SAS Users Guide: Basics and Statistics, Version 5 edition. Cary: SAS Institute Inc., 1985.

    Google Scholar 

  13. Altman R, Brandt K, Hochberg M et al. Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society. Osteoarthritis Cart. 1996;4:217–43.

    Article  CAS  Google Scholar 

  14. Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers; 1993:169–76.

    Google Scholar 

  15. Bellamy N, Muirden KD, Brooks P, Barroclough D, Tellus MM, Campbell J. A survey of outcome measurement procedures used in routine rheumatology outpatient practice by Australian rheumatologists. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 160.

  16. Bellamy N, Kaloni S, Pope J, Coulter K, Campbell J. A survey of outcome measurement procedures used in routine rheumatology outpatient practice by Canadian rheumatologists. Canadian Rheumatology Association Annual Meeting, Mont-Tremblant, Quebec. February 27-March 1. J Rheumatol. 1997;24:1425.

    Google Scholar 

  17. Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers; 1993:342–4,353–4.

    Google Scholar 

  18. Klinkoff AV, Bellamy N, Bombardier C et al. An experiment in reducing interobserver variability of the examination for joint tenderness. J Rheumatol. 1988;15:492–4.

    Google Scholar 

  19. Bellamy N, Muirden KD, Bendrups A et al. Effect of a standardized videotape on observer dependent outcome measures in rheumatoid arthritis. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 161.

  20. Bellamy N, Bachmeier C, Brooks P et al. Effect of a standardized videotape on observer-dependent outcome measures in osteoarthritis. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 162.

  21. Bellamy N, Muirden KD, Boyden K et al. Effect of a standardized videotape on observer dependent outcome measures in ankylosing spondylitis. Scientific Program of the Australian Rheumatology Association 40th Annual Scientific Conference, Brisbane. May 25–28, 1997, p. 159.

  22. Pope JE, Baron M, Bellamy N et al. Variability of skin scores and clinical measurements in scleroderma. J Rheumatol. 1995;22:1271–6.

    PubMed  CAS  Google Scholar 

  23. Green S, Buchbinder R, Forbes A, Bellamy N. A standardized protocol for measurement of range of movement of the shoulder using the plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res. 1997 (Submitted).

  24. Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers: 1993:11–24.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellamy, N., Bachmeier, C., Brooks, P.M. et al. Osteoarthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measures. Inflammopharmacol 5, 285–295 (1997). https://doi.org/10.1007/s10787-997-0006-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-997-0006-9

Keywords

Navigation